Sign up to save your podcasts
Or
Share Base to Base biotech podcast 64: Solving logistics challenges
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Base to Base biotech podcast 64: Solving logistics challenges
This week on Base to Base, we have a conversation with Bora Pharmaceuticals’ chief commercial officer Jean-Baptiste (JB) Agnus.
Bora Pharmaceuticals
Bora Pharmaceuticals is an international contract development and manufacturing organization (CDMO) specialising in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products.
With sites in North America and Asia, they deliver drug products to more than 100 markets around the world.
In May, Bora Group announced the acquisition of MacroGenics’ GMP manufacturing operations for $122.5m.
To get in touch with guest suggestions, or to sponsor or advertise on the podcast, please email [email protected]
View all episodes
By Jim CornallThis week on Base to Base, we have a conversation with Bora Pharmaceuticals’ chief commercial officer Jean-Baptiste (JB) Agnus.
Bora Pharmaceuticals
Bora Pharmaceuticals is an international contract development and manufacturing organization (CDMO) specialising in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products.
With sites in North America and Asia, they deliver drug products to more than 100 markets around the world.
In May, Bora Group announced the acquisition of MacroGenics’ GMP manufacturing operations for $122.5m.
To get in touch with guest suggestions, or to sponsor or advertise on the podcast, please email [email protected]